University of Kentucky

UKnowledge
DNP Projects

College of Nursing

2015

Assessment of Patient Barriers to and Facilitators of Screening
Colonoscopy: Utilizing Patient Perspectives to Formulate
Recommendations to Improve Colorectal Cancer Screening Rates
Heather N. Cox
University of Kentucky, heather.barker@uky.edu

Right click to open a feedback form in a new tab to let us know how this document benefits you.

Recommended Citation
Cox, Heather N., "Assessment of Patient Barriers to and Facilitators of Screening Colonoscopy: Utilizing
Patient Perspectives to Formulate Recommendations to Improve Colorectal Cancer Screening Rates"
(2015). DNP Projects. 43.
https://uknowledge.uky.edu/dnp_etds/43

This Practice Inquiry Project is brought to you for free and open access by the College of Nursing at UKnowledge. It
has been accepted for inclusion in DNP Projects by an authorized administrator of UKnowledge. For more
information, please contact UKnowledge@lsv.uky.edu.

Running head: ASSESSMENT OF PATIENT BARRIERS

DNP Practice Inquiry Project Report
Assessment of Patient Barriers to and Facilitators of Screening Colonoscopy: Utilizing
patient perspectives to formulate recommendations to improve colorectal cancer
screening rates.

H. Nicole Barker Cox, BSN, RN, CGRN

University of Kentucky
College of Nursing
Spring 2015

Lynne A. Jensen, PhD, APRN, BC – Committee Chair
Nora Warshawsky, PhD, RN – Committee Member
John Shekleton, M.D. – Committee Member, Clinical Mentor

ASSESSMENT OF PATIENT BARRIERS
Dedication
“Some people weave burlap into the fabric of our lives, and some weave gold thread.
Both contribute to make the whole picture beautiful and unique.”
~ Anonymous
This capstone project is dedicated to those who made the completion of my
educational journey possible. To my husband, Thadis Cox, your strength and
perseverance has carried me through the toughest of times and I thank you for your
love and encouragement. To my sweet daughter, Ava, you are my heart and you
have given my life a new purpose and source of strength. To my parents, Phillip and
Susan Barker, you have made me the person I am today and it is through your
unfailing love and support that I have been able to reach for and achieve my dreams.
To my academic advisor, Lynne Jensen - Time is such a precious gift in this life, and
the fact you were willing to devote so much of it to ensure my success in this
program leaves me speechless. I am truly thankful. To my fellow co-workers at
Frankfort Regional Medical Center, without your willingness to cover in my absence
and without your continued love and support, this would not have been possible.
To my dear friend, Somer Robinson, you’ve been an incredible source of
encouragement over the years and I thank you.
***

For all of you are golden threads in the fabric of my life.

ASSESSMENT OF PATIENT BARRIERS

Acknowledgements
I would like to thank the following individuals for their guidance and support:
Lynne A. Jensen, PhD, APRN, BC (Academic Advisor and Committee Chair): for
serving as my advisor and making the successful completion of this program
possible. Your passion for nursing and your commitment to the betterment of
others is truly inspiring.
Nora Warshawsky, PhD, RN (Committee Member): for the time you dedicated to
the arduous editing process. Your dedication to nursing education is reflected in
your ever-present enthusiasm and encouraging spirit. Thank you.
John Shekleton, M.D. (Committee Member, Clinical Mentor): for the time you were
willing to devote amidst the business of your life and clinical practice. Thank you.
Lori Ivy, RN, MSN, CPHQ (Frankfort Regional Medical Center, Research
Coordinator): for your encouragement as well as your persistence and leadership
during the IRB process.

iii

ASSESSMENT OF PATIENT BARRIERS

Table of Contents
Acknowledgements .....................................................................................................................iii
List of Tables..................................................................................................................................v
List of Figures ................................................................................................................................vi
DNP Practice Inquiry Project Introduction ......................................................................1
Manuscript 1 ..................................................................................................................................6
Manuscript 1 Appendix A .........................................................................................................19
Manuscript 2 ..................................................................................................................................21
Manuscript 2 Appendix A .........................................................................................................42
Manuscript 3 ..................................................................................................................................48
Manuscript 3 Appendix A .........................................................................................................67
DNP Practice Inquiry Project Conclusion ...........................................................................73
Compliance Statement ...............................................................................................................77
IRB Approval .................................................................................................................................78

iv

ASSESSMENT OF PATIENT BARRIERS

List of Tables
Manuscript 1
Table 1..............................................................................................................................................8
Manuscript 2
Table 1..............................................................................................................................................38
Manuscript 3
Table 1..............................................................................................................................................58
Table 2..............................................................................................................................................59
Table 3..............................................................................................................................................61

v

ASSESSMENT OF PATIENT BARRIERS

List of Figures
Manuscript 1
Figure 1 ............................................................................................................................................14
Manuscript 3
Figure 1 ............................................................................................................................................56
Figure 2 ............................................................................................................................................57

vi

ASSESSMENT OF PATIENT BARRIERS

DNP Practice Inquiry Project Introduction
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Colorectal cancer (CRC) will be diagnosed in approximately one out of every twenty
Americans (5%) at some point during their lifetime, ranking it the third most
commonly diagnosed cancer among all cancer types (American Cancer Society
[ACS], 2014; Centers for Disease Control and Prevention [CDC], 2014a). It is the
second leading cause of cancer-related death and was projected to kill more than
50,000 people in the United States (U.S.) in 2014 (CDC, 2014a). The economic
burden of treating CRC is high, as the costs of CRC-related care to the Medicare
program was projected to increase to over $14 billion in 2020 from approximately
$7.5 billion in 2000 (Yabroff, Mariotto, Feuer, & Brown, 2008). However, with
proper screening, CRC-related incidence, mortality, and cost of treatment could be
significantly reduced.
The American College of Gastroenterology (ACG) and the U.S. Preventative
Services Task Force (USPSTF) agree that CRC screening should include the
following: 1) home fecal occult blood test (FOBT) or fecal immunochemical test
(FIT) yearly; 2) flexible sigmoidoscopy every five years, plus FOBT/FIT every three
years; and/or 3) colonoscopy every 10 years (Rex et al., 2009; USPSTF, 2008). A
systematic review of cost-effectiveness analyses revealed that the use CRC screening
methods equates to an average cost-effectiveness ratio of $10,000 to $30,000 per
life-year saved when compared to no screening (Pignone, Heorgem, & Mandelblatt,
2002). Colonoscopy remains the gold-standard screening exam for CRC because it
allows for visualization of the colon as well as the identification and removal of precancerous lesions (polyps).
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During a screening colonoscopy, polyp removal can prevent the development
of CRC by 80%, which is why evidence-based practice strategies have been adopted
by many providers to increase recommendations and orders for CRC screening tests
(U.S. Department of Health and Human Services [HHS], n.d.; Sarfaty, 2008). Despite
the success of evidence-based strategies to increase recommendations and orders
for screening colonoscopy, it was determined that among individuals who receive
orders for screening colonoscopy, approximately 50% will fail to follow through
with the procedure (Sequist, Zaslavsky, Marshall, Fletcher, & Ayanian, 2009). This
practice inquiry project was developed to determine the barriers and facilitators of
screening colonoscopy from the patient perspective and includes the following three
manuscripts:
Manuscript one is an investigation into the significance and impact of
colorectal cancer, associated guidelines and practice tools for screening and
management.
Manuscript two is a review of literature to evaluate the existing interventions
aimed at increasing provider compliance with CRC screening in primary care.
Manuscript three describes the development and implementation of a
qualitative study to determine patient-identified barriers and facilitators to
screening colonoscopy, and its potential impact on future clinical practice
and research.
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Epidemiology and Impact
In the United States (U.S.), colorectal cancer (CRC) remains the third most
common of all cancer types and is the second leading cause of cancer deaths (U.S.
Cancer Statistics Working Group, 2013). In 2009, “136, 717 people in the United States
were diagnosed with colorectal cancer, including 70, 223 men and 66, 494 women” (U.S.
Cancer Statistics Working Group, 2013). Furthermore, colorectal cancer deaths totaled
51, 848, of which, 26, 806 were men and 25, 042 were women (U.S. Cancer Statistics
Working Group, 2013). The per year age-adjusted death rate, calculated from the 20052009 U.S. data, was 16.7 per 100,000 men and women (National Cancer Institute [NCI],
2009). These numbers are projected to increase annually if screening efforts do not
improve.
The National Cancer Institute’s Surveillance and Epidemiology and End Results
(SEER) report found that “from 2005-2009, the median age at diagnosis for cancer of the
colon and rectum was 69 years of age” and the “median age at death was 74 years of age”
(NCI, 2009, p. 1). Although CRC has been diagnosed in children and young adults, its
occurrence is rare. Therefore, the population upon which screening efforts are primarily
focused is middle-aged adults and the elderly ranging from ages 50 to 75 years. In the
U.S., between 2005 and 2009, incidence rates among age specific groups were as
follows: 0.1% were diagnosed under age 20; 1.1% between 20 and 34; 4.0% between 35
and 44; 13.4% between 45 and 54; 20.4% between 55 and 64; 24.0% between 65 and 74;
25.0% between 75 and 84; and 12.0% 85+ years of age” (NCI, 2009, p.1). Mortality
rates per age group were: “0.0% died under age 20; 0.6% between 20 and 34; 2.5%
between 35 and 44; 8.6% between 45 and 54; 16.5% between 55 and 64; 22.0% between
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65 and 74; and 29.0% between 75 and 84; and 20.8% 85+ years of age” (NCI, 2009, p.
1).
Screening can assist with both the early diagnosis of CRC in its treatable stages,
and with the detection of precancerous lesions (polyps) that, once removed, can prevent
CRC development. The table below is from the NCI’s SEER Stat Fact Sheet.
Table 1.
Stage Distribution and 5-year Relative Survival by Stage at Diagnosis for 2002-2008
Stage at Diagnosis

Stage
Distribution (%)

Localized (confined to primary site)

39

5-year
Relative
Survival (%)
89.9

Regional (spread to regional lymph nodes)

36

69.9

Distant (cancer has metastasized)

20

11.9

Unknown (unstaged)

5

33.9

Note. Table figures depict percentages among males and females and all races (NCI,
2009, p. 1)
Regardless of the fact that colorectal cancer screening is a relatively safe and
effective way to detect and even prevent the development of CRC cancer, “current levels
of screening in this country lag behind those of other effective screening tests” (United
States Preventative Services Task Force [USPSTF], 2008, p. 627). In the U.S. only
52.1% of eligible adults are being screened for colorectal cancer (U.S. Department of
Health and Human Services [HHS], 2012). This disease is easily detectible and highly
preventable when proper screening is implemented. The initiation of CRC screening
typically occurs as a result of a primary care provider’s (PCP) recommendation and they
are usually the main source of specialist referral for the previously mentioned screening
modalities (Ornstein, Nemeth, Jenkins, & Nietert, 2010). Sarfaty (2008) states,
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“Practitioners must become aware that their recommendation is the single most
influential factor in persuading individuals to be screened for cancer (p. 9).
Purpose Statement
A precipitous decrease in the number of newly diagnosed colorectal cancers
would occur if adenomatous colorectal polyps were removed prior to their transformation
into cancers. Based on clinical evidence, screening (to include both prevention and
detection tests) is to begin at age 50 among those of average risk and earlier for
individuals considered to be at high risk (Sarfaty, 2009). Multiple strategies have been
attempted in primary care practices to increase provider compliance with cancer
screening, and these strategies have been evaluated for effectiveness. However, multistrategy interventions, as opposed to single-strategy interventions (i.e. Electronic Medical
Record (EMR) or paper chart reminders), have proven to be most successful at increasing
PCP screening rates (Baker et al., 2009; Ornstein et al., 2010). The following sections of
this paper will review the Healthy People 2020 objectives regarding CRC screening, the
current CRC screening guidelines, and an evidence-based strategy that can be used to
manage the issue of CRC screening among PCPs.
Healthy People 2020
Healthy People.gov is a federally funded website that provides national health
goals for the U.S. population. Multiple benchmarks have been created and continuous
monitoring takes place in an effort to 1) “encourage collaborations across communities
and sectors”; 2) “empower individuals toward making informed health decisions; and 3)
“measure the impact of prevention activities” (U.S. Health and Human Services [HHS],
2012, p.1). Healthy People 2020 also created a set of objectives, known as the Leading
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Health Indicators (LHI), to draw attention to higher priority health issues as well as the
corresponding activities designed to address them.
To “increase the proportion of adults who receive a colorectal cancer screening
based on the most recent guidelines in 2008” is a Leading Health Indicators of Healthy
People 2020 (HHS, 2012). Baseline data reveals that among adults age 50 to 75 years,
only 52.1% were appropriately screened for colorectal cancer based on the most current
2008 guidelines (HHS, 2012). The set target for CRC screening is to increase the
screening rate from 52.1% to 70.5% by year 2020 (HHS, 2012).
CRC Screening Tools
The American College of Gastroenterology (ACG) is the primary source for the
current screening guidelines that ultimately determine the age group(s) for CRC
screening as well as the appropriate screening tools used to assess for the presence of
cancers of the colon and rectum. Recommended guidelines were recently revised by the
ACG and highlight the division of tests into cancer prevention and cancer detection tests.
The recommendations include the following screening modalities: screening of averagerisk adults aged 50-75 year by way of fecal immunochemical test (FIT), or highsensitivity fecal occult blood test (FOBT) yearly, high-sensitivity FOBT every 3 years
along with flexible sigmoidoscopy every 5 years, or colonoscopy every 10 years (Rex et
al., 2009). Furthermore, special population considerations also include screening of
African Americans at age 45 and screening of individuals with a positive family history
(defined as a first-degree relative) 10 years prior to the age of the relative’s CRC
diagnosis (Rex et al., 2009). Below a full description of the ACG screening
recommendations is presented in an easy to read, bulleted listed that also includes the
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category and strength of recommendation (See Appendix A for the Category of Evidence
and Strength of Recommendation Chart) (Rex et al., 2009, p. 2):
CRC Screening Recommendations
Preferred CRC Screening Recommendations
Cancer prevention tests should be offered first. The preferred CRC prevention test
is colonoscopy every 10 years, beginning at age 50 (Grade 1 B). Screening should
begin at age 45 years in African Americans (Grade 2 C).
Cancer detection test. This test should be offered to patients who decline
colonoscopy or another cancer prevention test. The preferred cancer detection test
is annual FIT for blood (Grade 1 B).
Alternative CRC Prevention Tests
Flexible sigmoidoscopy every 5–10 years (Grade 2 B)
Computed tomography (CT) colonography every 5 years (Grade 1 C)
Alternative Cancer Detection Tests
Annual Hemoccult Sensa (Grade 1 B)
Fecal deoxyribonucleic acid (DNA) testing every 3 years (Grade 2 B)
Recommendations for Screening When Family History is Positive but Evaluation for
Hereditary Non-polyposis Colorectal Cancer (HNPCC) Considered Not Indicated
Single first-degree relative with CRC or advanced adenoma diagnosed at age ≥60
years
Recommended screening: same as average risk (Grade 2 B)
Single first-degree with CRC or advanced adenoma diagnosed at age <60 years or
two first-degree relatives with CRC or advanced adenomas
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Recommended screening: colonoscopy every 5 years beginning at age 40 years or
10 years younger than age at diagnosis of the youngest affected relative (Grade 2
B)
Clinical Practice Guideline for Management
To manage the issue of inadequate and improper CRC screening by PCPs, an
evidence-based clinical practice guideline should be implemented in primary care offices.
The National Colorectal Cancer Roundtable (an activity of The American Cancer Society
and The Center for Disease Control and Prevention), in collaboration with Thomas
Jefferson University Department of Family Medicine, published a document by Mona
Sarfaty, M.D. entitled, “How to Increase Colorectal Cancer Screening Rates in Practice:
A Primary Care Clinician’s Evidence-Based Toolbox and Guide 2008.” The four main
goals of this published guide are as follows: 1) To inform PCPs and their office managers
about ways they can help prevent CRC among patients through proper screening; 2) To
inspire PCPs to utilize appropriate screening recommendations to reduce the morbidity
and mortality of CRC and other cancers; 3) “To facilitate effort of office-based clinicians
to reduce disparities by applying screening guidelines on a universal basis to the ageappropriate population”; and 4) To improve prevention strategies in primary care
facilities by use of the guide’s tools and approaches (Sarfaty, 2008, p. 13).
An accompanying action plan to the guide entitled, “How to Increase Preventative
Screening Rates in Practice: An Action Plan for Implementing a Primary Care Clinician’s
Evidence-Based Toolbox and Guide” was developed by the National Colorectal Cancer
Roundtable (NCCRT). It essentially breaks down and simplifies the 130-page guide to
be used as a quick reference for PCPs. Within the action plan, there are four specific
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recommendations: 1) “Implement practice changes to achieve the Four Essentials”
(discussed below); 2) “Take steps to identify and screen every age-appropriate patient”;
3) “Involve your staff, and put office systems in place”; and 4) “Follow a continuous
improvement model to develop and test changes” (NCCRT, 2008, p. 4).
Sarfaty (2008) recommends utilization of the Plan-Act-Study-Adjust (PASA)
model. Practices must develop a plan that involves staff members in the creation of a
system for CRC screening that is founded upon the Four Essentials and includes
extraction of baseline screening rates. Staff members within the practice are then
prompted to act upon the developed plan. The results of the plan are studied (i.e.
screening rates) and then disseminated to staff members. Finally, the plan is adjusted and
potential improvement opportunities are identified based on the results.
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Figure 1.
Improve Cancer Screening Rates Using the Four Essentials

Note. From NCCRT (2008).
As mentioned above, the toolbox and guide uses a multi-strategy approach that
highlights Four Essentials to improve CRC screening rates, and within each essential
specific tasks are identified and practice tools/references are made available for use.
Essential #1 requires that providers make a CRC screening recommendation to every
eligible and at-risk patient and determine a method to assess patient CRC risk as well as
receptiveness to screening (Sarfaty, 2008). Practice tools made available within the guide
include printable reference handouts to help providers: 1) understand CRC screening
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options, 2) assess for patient CRC risk, and 3) assess patient readiness to be screened.
Essential #2 requires the development of a CRC screening policy that a) determines
individual CRC risk level, b) identifies local medical resources, c) considers patient CRC
screening preference, and e) attends to office implementation (Sarfaty, 2008). Essential #
2 is a vital element as it “ensures consistency over time by clearly articulating the
intentions of the practitioner and the practice” (Sarfaty, 2009, p. 19). Practice tools
available for reference include: 1) sample CRC screening policies, 2) CRC screening
algorithms and a FOBT flow chart; 2) an office policy worksheet that simplifies the
policy into steps and delineates roles within the practice; and 3) a guide on how to
develop a quality referral system in primary care. Essential # 3 requires practices be
persistent with patient and provider reminders. Patient reminders should include options
for patient-appropriate educational materials and cues to action, while provider reminders
should include elements such as chart prompts, EMR audits and feedback, EMR
reminders, and screening log sheets (Sarfaty, 2008). Practice tools include 1) information
from the ACP Center for Practice and Innovation and AAFP Center for Health IT on how
to purchase an effective EMR system and 2) a printable sample chart prompt and sample
CRC tracking log. Essential # 4 requires measurement of progress within the practice
and involves conducting regular meetings with staff members to “discuss how the system
is working” and make any necessary adjustments (Sarfaty, 2009, p. 8). It is
recommended that staff or a local consultant company be utilized to perform the audits.
Practice tools include a printable practice performance handout that lists steps to a quality
chart audit, and an Internal Practice Questionnaire that collects staff feedback to assess
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goal attainment, usefulness of the CRC screening materials and documentation, and staff
performance and satisfaction.
Conclusion
Colorectal cancer is the second leading cause of cancer death and remains the
third most commonly diagnosed cancer (U.S. Cancer Statistics Working Group, 2013).
Although CRC is easily detected and highly preventable through the use of prevention
and detection tests (i.e. colonoscopy, CT colonography, flexible sigmoidoscopy, and
FOBT/FIT), screening rates in the U.S. continue to be startlingly low at only 52.1%
(HHS, 2012). With a CRC screening target set at 70.5% by Healthy People 2020 and
75% by the American Cancer Society, it is essential for PCPs to implement evidencebased strategies within their clinics in order to meet these goals and to decrease morbidity
and mortality caused by this disease (HHS, 2012 and Sarfaty, 2009).
The National Colorectal Cancer Roundtable developed an action plan based on
the document by Mona Sarfaty, M.D. entitled, “How to Increase Colorectal Cancer
Screening Rates in Practice: A Primary Care Clinician’s Evidence-Based Toolbox and
Guide 2008” that gives PCPs step-by-step instructions and accompanying resources and
tools to help their clinics reach and maintain the target screening goals (NNCRT, 2008
and Sarfaty, 2008). The NCCRT (2008) developed a flowchart that provides a complete
pictorial depiction of the evidence-based guide (Figure 1).
Evidence-based management guidelines and toolkits have been developed to
facilitate provider compliance with CRC screening recommendations. All that remains is
for PCPs to implement them in practice and evaluate their effectiveness in achieving the
goals set forth by Healthy People 2020.
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APPENDIX A
Category of Evidence and Strength of Recommendation
Methods Used to Analyze the Evidence: Review of Published Meta-Analyses and
Systematic Review
Grade of
Recommendation/Description

Benefit vs.
Risk and
Burdens

Methodological
Quality of
Supporting
Evidence

Implications

1A/Strong recommendation,
high-quality evidence

Benefits
clearly
outweigh
risk and
burdens, or
vice versa

Randomized
controlled trials
(RCTs) without
important
limitations or
overwhelming
evidence from
observational
studies

Strong
recommendation,
can apply to most
patients in most
circumstances
without reservation

1B/Strong recommendation,
moderate quality evidence

Benefits
clearly
outweigh
risk and
burdens, or
vice versa

RCTs with
important
limitations
(inconsistent
results,
methodological
flaws, indirect, or
imprecise) or
exceptionally
strong evidence
from
observational
studies

Strong
recommendation,
can apply to most
patients in most
circumstances
without reservation

1C/Strong recommendation,
low-quality or very lowquality evidence

Benefits
clearly
outweigh
risk and
burdens, or
vice versa

Observational
studies or case
series

Strong
recommendation
but may change
when higher
quality evidence
becomes available

2A/Weak recommendation,
high-quality evidence

Benefits
closely
balanced
with risks
and burden

RCTs without
important
limitations or
overwhelming
evidence from

Weak
recommendation,
best action may
differ depending
on circumstances
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Grade of
Recommendation/Description

Benefit vs.
Risk and
Burdens

Methodological
Quality of
Supporting
Evidence

Implications

observational
studies

or patients' or
societal values

2B/Weak recommendation,
moderate quality evidence

Benefits
closely
balanced
with risks
and burden

RCTs with
important
limitations
(inconsistent
results,
methodological
flaws, indirect, or
imprecise) or
exceptionally
strong evidence
from
observational
studies

Weak
recommendation,
best action may
differ depending
on circumstances
or patients' or
societal values

2C/Weak recommendation,
low-quality or very lowquality evidence

Uncertainty
in the
estimates of
benefits,
risks, and
burden;
benefits,
risk, and
burden may
be closely
balanced

Observational
studies or case
series

Very weak
recommendations;
other alternatives
may be equally
reasonable

Note. Table from Rex et al., 2008, p. 2. Methods used: Review of Published MetaAnalyses and Systematic Review
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Abstract
Purpose: Multiple studies have been published to evaluate the effectiveness of
interventions developed to increase colorectal cancer screening adherence in the primary
care setting. An integrative review was conducted to determine which interventions were
shown to be most successful at increasing CRC screening rates among primary care
providers.
Methods: An integrative literature search was conducted among studies published between
2001 and 2011. The following online databases were used to conduct the literature search:
(a) Cumulative Index to Nursing and Allied Health Literature (CINAHL); (b) MEDLINE
(Ovid SP); and (c) PubMed (digitally produced file by the National Library of Medicine in
the Biological sciences). The key words, phrases, and/or search terms used included:
“colorectal screening,” “cancer screening,” “primary care and screening,” “screening
interventions,” “cancer prevention,” “colon cancer screening,” “cancer screening and
interventions,” and “cancer prevention and primary care.” Included were publications that
(a) assessed the effects of interventions formulated to increased CRC screening
compliance; (b) had screening-eligible adults as participants; (c) had a quantitative or
qualitative design; (d) were written in English; and (e) were published between January
2001 and October 2011.
Results: Six articles met the inclusion criteria. Studies were separated into 2 specific
groups for further evaluation and critical analysis – Multi-Strategy Intervention Studies
and Combined Physician/Patient Reminder Intervention Studies.
Conclusions: Multi-strategy interventions are most successful at increasing CRC
screening rates and include several key components (i.e. audit/feedback, education,
physician and patient reminders, and expanded non-physician staff role). Patient and/or
physician reminders do increase CRC screening rates but the increase is modest and should
not be used as sole intervention but rather used in combination. Effective patient-provider
communication is a key factor in determining CRC screening recommendation and exam
completion, which reveals a provider education opportunity. Interventions that
demonstrate an increase in screening colonoscopy orders resulted in a completion rate of
only 50%. Patient perspectives regarding barriers to and facilitators of screening
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colonoscopy completion could be valuable with regard to development of future combined
patient- and provider- CRC screening interventions.
In the United States, colorectal cancer (CRC) remains the third most common of
all cancer types and is the second leading cause of cancer deaths (U.S. Preventative
Services Task Force [USPSTF], 2008). In 2008, it was estimated that 148,810 people
would be diagnosed with CRC and 49,960 people would die as a result of this highly
detectable and preventable disease (USPSTF, 2008). It was also projected that the
achievement of proper screening goals could save approximately 18,800 lives annually
(USPSTF, 2008). However, “current levels of screening in this country lag behind those
of other effective screening tests” (USPSTF, 2008, p. 627). In 2008 only 56.3% of
eligible adults 50 years and older reported having received CRC screening (U.S.
Department of Health & Human Services [HHS], 2011).
Screening can assist with both the early diagnosis of CRC in its treatable stages,
and with the detection of precancerous lesions (polyps) that, once removed, can prevent
CRC development. Recommended guidelines were recently revised to include the
following: screening of average-risk adults aged 50-75 years by way of fecal
immunochemical test (FIT) or high-sensitivity fecal occult blood test (FOBT) yearly,
FOBT/FIT every 3 years along with flexible sigmoidoscopy every 5 years, or
colonoscopy every 10 years (Rex, et al., 2008; USPSTF, 2008). The initiation of CRC
screening typically occurs as a result of primary care provider (PCP) recommendation
and they are usually the primary source of referral for the screening modalities (Ornstein,
Nemeth, Jenkins, & Nietert, 2010).
An integrative review was conducted to examine the impact of interventions that
have been used to increase CRC screening compliance by primary care providers.
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Findings could potentially guide the development of a multifaceted intervention that
incorporates evidence-based findings from previous interventional studies to further
increase CRC compliance.
Scope of the Review
An integrative review was conducted on the impact of interventions used to
increase PCP screening compliance with CRC guidelines among eligible patients. The
results of these interventions were summarized and analyzed to determine which
intervention(s) had the greatest impact on improving CRC screening rates among PCPs.
The goal of the review was to then determine whether a multifaceted intervention, using
the best outcomes from previously studied evidence-based interventions, could be
formulated to further increase compliance rates.
Design
The purpose of this review was to understand what interventions have increased
CRC screening compliance among primary care providers. Included were publications
that (a) assessed the effects of interventions developed to increased CRC screening
compliance; (b) included screening-eligible adults as participants; (c) had a quantitative
or qualitative design; (d) were written in English; and (d) were published between
January 2001 and October 2011. References that (a) were not published works (i.e. theses
and dissertations); (b) written in any language other than English; and (c) focused strictly
on other cancer screenings (i.e. breast, prostate, cervical, etc.), cancer diagnosis,
therapeutic and/or diagnostic interventions, or programs to only increase patient
compliance were excluded.
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Methods
The following online databases were used to conduct the literature search: (a)
Cumulative Index to Nursing and Allied Health Literature (CINAHL); (b) MEDLINE
(Ovid SP); and (c) PubMed (digitally produced file by the National Library of Medicine
in the Biological sciences). The key words, phrases, and/or search terms used included:
“colorectal screening,” “cancer screening,” “primary care and screening,” “screening
interventions,” “cancer prevention,” “colon cancer screening,” “cancer screening and
interventions,” and “cancer prevention and primary care.” The literature review served to
investigate the impact of various interventions on colorectal screening compliance among
primary care providers.
Each study was reviewed for content to ensure that the primary focus was
colorectal screening compliance among primary care providers. The articles that met the
inclusion criteria then underwent a more in depth and thorough review, to assure the
study met the inclusion criteria. Critical analysis of the content reviewed the validity,
reliability, and applicability of the study characteristics, findings, and results (O’
Mathuna, Fineout-Overholt, & Johnston, 2011). Specifically, the sample and setting
characteristics, procedures/methods for data collection, and strengths and weaknesses
were evaluated.
Outcome
The interventional studies included in the review were clustered according to
similarity, and included two specific intervention types: (1) multi-strategy intervention
and (2) combined physician and patient reminder intervention. A table was constructed
to present the summarized findings of the review (see Appendix A). Six studies were
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retained for the review. Several references were excluded (n = 10) as the primary focus
was on the investigation of patient-physician relationship dynamics, the exploration of
attitudes/beliefs, and patient compliance. Also excluded, were the National Colorectal
Cancer Roundtable Report and a narrative review.
Studies included in the review were either a randomized controlled trial (RCT) (n
= 4) or had a quasi-experimental design (n = 2). Multidisciplinary teams comprised of
medical doctors and/or researchers in science, nursing, or psychology conducted most of
the studies. The studies that investigated multi-strategy interventions included one RCT
(Ornstein et al., 2010) and one quasi-experimental study (Baker et al., 2009), while the
studies that investigated a combined physician and patient interventions included three
RCTs (Ayanian, Sequist, Zaslavsky, & Johannes, 2008; Ling et al., 2009; Sequist et al.,
2009) and one quasi-experimental study (Geller et al., 2008).
Findings
Among the interventions that utilized the EMR for the purpose of baseline data
and continuous performance audits, the EMR was found to be beneficial because it
provided a method to evaluate and reinforce the quality improvement interventions being
implemented (Baker, et al., 2009 & Ornstein et al., 2010). On the other hand, it was
determined that incomplete CRC screening documentation within the EMR made it
difficult to use during the auditing process, highlighting the need for and importance of
effective systems (Ayanian et al., 2008). When solely utilized as a tool for provider
reminders, EMRs did not produce a significant effect on CRC screening referrals or exam
completion (Baker et al., 2009, Ornstein, et al., 2010, & Sequist et al., 2009). When
patient reminders were also employed as a sole intervention (regardless of reminder
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method) to increase CRC screening, they too, only produced a modest increase in
screening referral and completion rates (Baker et al., 2009, Ornstein, et al., 2010, &
Sequist et al., 2009). Rather, more benefit was found among studies that utilized patient
and provider reminder methods in combination with other intervention strategies.
Conflicting findings were identified among studies that implemented provider
education as an intervention to increase CRC screening referrals. When data analysis
isolated the effects of provider education, Baker et al. (2009) determined that provider
education alone yielded a limited effect, while Ornstein et al. (2010) found best-practice
dissemination among providers to increase recommendation for and receipt of CRC
screening. However, when patients received education regarding personalized need for
CRC screening and providers received subsequent notification of patient CRC screening
status, there was an increased promotion of 1) provider-patient discussion, provider
recommendation, and positive patient intention to obtain screening (Geller et al., 2008).
The importance of combined education strategies that involve both patients and providers
is thereby emphasized.
Lastly, ineffective patient-provider counseling and communication has led to a
decline in informed decision-making among patient concerning CRC screening (Ling et
al., 2009 & Sequist et al., 2009). During observed patient visits, the biggest barrier to
effective communication between providers and patients was found to be the
overwhelming amount of competing demands that arise during the patient encounter
(Ling et al., 2009). The importance of CRC screening is not being appropriately
discussed and therefore, there is a deficiency in CRC screening referrals.

27

ASSESSMENT OF PATIENT BARRIERS
Multi-Strategy Intervention Studies
Ornstein et al. (2010). A randomized trial was conducted in 32 primary care practices
over a two-year period to evaluate the impact of a three-phase quality improvement
intervention on CRC screening. Phase one of the intervention provided PCPs in the
intervention group with feedback from an EMR audit that evaluated CRC screening
status of eligible patients. This information was then used to facilitate educational
discussions during practice site visits (phase 2), which were specifically “designed to
help practices implement an improvement model to adopt strategies to improve CRC
screening” (p. 900). Phase three consisted of two annual meetings where physician and
nurse liaisons from each practice shared its ‘best-practice’ approaches.
Overall, this study revealed that the utilization of a multi-strategy intervention
within primary care practices using EMRs could improve their rates of CRC screening.
There was a significant improvement (from 60.7% to 71.2%) in patients being up-to-date
(UTD) with CRC screening in the intervention practices compared to patients in the
control practices (from 57.7% to 62.8%). There was also a greater increase in provider
recommendation of CRC screening within the intervention practices – an adjusted
difference of 7.9% (95% confidence interval, 6.3% - 9.5%). There was also an increased
use of FOBT in the intervention group suggesting that such a test could be a practical
alternative for patients that did not receive an endoscopic form of screening and that its
viability should be evaluated. Variability was also found in screening among practices
during the study, where the best-performing practices screened 80% of eligible patients
and worst performing practices only screened 50% or less. This finding suggests that
best-practice adoption among practices have the potential to increase screening rates.
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There were limitations in this study. Despite the fact intervention practices used
EMR audits to ensure accurate data extraction, ascertainment bias may have caused
information regarding CRC screening data to be incomplete. This bias may have
occurred as a result of patients in the intervention practices being more consistently
questioned about previous screening than those in the control practices. Furthermore,
practices that were included used an EMR, had the advantage of research team
involvement, and voluntarily enrolled in an improvement intervention making
generalizability of the findings across primary care practices questionable. There was
also no true control group due to the fact that “control group practices received an
introductory site visit to discuss CRC screening and had the same EMR functionality as
those in the intervention group” (p. 906). However, despite the limitations, this study
used appropriate statistical analysis and methodical approaches demonstrate that practices
following this type of multi-strategy intervention can improve their CRC screening rates.
Baker et al. (2009). A pilot-study was conducted in seven university-owned primary
care practices that comprise the University of Utah Community Clinics and Utah
Research Health Network, which cares for 100,000 patients. Included in the study, were
patients aged 50 years or greater that were seen between January 1, 2003 thru October 31,
2006, and whose CRC screening was not UTD upon visit. Baker et al. (2009)
implemented a three-phase intervention to test the effects of an expanded medical
assistant (MA) role on CRC screening among eligible patients – the rate of screening
colonoscopy orders being the key outcome measure.
A baseline EMR audit was performed for post-intervention comparative analysis.
Phase one consisted of upgraded EMR “pop-up” reminders for PCPs with no immediate
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effect on CRC screening rates. Phase-two provided CRC screening education to PCPs,
which lead to an increase of 7.5% in CRC screening referral rates during the following
month. The third-phase focused on the expansion of the MA role by 1) providing CRC
screening education; 2) using scripts to initiate a CRC screening discussions with any
eligible patients (per EMR “pop-up” reminder); and 3) using a manual CRC screening
log to report the results of the CRC screening discussion; and 4) entering a preliminary
CRC screening order (with patient permission), to be confirmed or rejected by the PCP.
After this final phase was implemented, the mean monthly referral rate for colonoscopy
increased from a baseline of 6.0% to 13.4% (p<0.01).
Although computerized reminders and PCP education alone were not effective,
their use, combined with expanded non-physician roles, provided the most benefit. This
was because non-physician staff members managed the flow of patient activity in the
primary care offices. Investigators identified the need to evaluate “MA and physician
response to the intervention and to identify the true rate of completed screening” (p. 358).
The reasons being 1) only specific fields within the EMR were queried for actual results
of colonoscopy; 2) progress and free text notes were not included, and 3) completion of
other forms of acceptable screening modalities were not included. Therefore, the actual
baseline colonoscopy referral or CRC screening rate may have been underestimated.
Furthermore, the rapid progression through each intervention phase made it “impossible
to isolate the effect of any one phase” (p. 358). Lastly, the fact that the participating
clinics were university-owned and operated, and that a group within the university
conducted the study, the ease at which the practices were able to implement these
changes could be directly attributed to their rather advantageous circumstances (i.e. close
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ties with the research network, unified EMR implementation, and unified management).
This potentially limits the study’s ability to generalize its findings and renders the need
for future research to be conducted in more diverse practice settings.
Combined Physician / Patient Reminder Studies
Geller et al. (2008). Five primary care practices in rural communities implemented the
use of a computerized tablet, or Patient/Provider Communication Assistant (PPCA), that
was responsible for data collection, patient education, and personalization of printed
patient and provider notes to encourage CRC screening discussions. A pre-/post- quasiexperimental design was used along with mixed model analyses during the intervention
and comparison phases to assess the practices on “provider discussions about CRC
screening, provider recommendation, and patient intention to be screened” (p. S36). The
comparison group for this study was comprised of patients that expressed interest to
participate in the study after their scheduled PCP office visit. A research assistant (RA)
then obtained informed consent and conducted an exit interview consisting of questions
that measured “demographics, risk factors, CRC screening history, interactions with the
provider, and plans to be screened” (p. S40). As for the intervention group, eligible
patients were engaged in a tablet-based, computerized educational program, using a
Patient/Provider Communication Assistant (PPCA), upon arrival and prior to their
scheduled primary care visit. After completing the interactive PPCA education, patients
were given personalized CRC screening recommendations based on questions they
answered during the program. A printed copy of the recommendations was given to the
patient and an additional copy was placed in the patient’s chart to be reviewed by the
PCP.
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Overall, the PPCA “promoted patient-provider discussion, provider
recommendations, and positive patient intentions to obtain screening” (p. S40). Patients
were also complimentary of the PPCA’s ease of use. Strengths of the study included its
recruitment processes as the intervention and comparison groups were selected from each
of the five primary care practices. Generalizability is supported by the fact that the study
results consistently “favored the intervention group across all 5 practices” (p. 41).
Furthermore, the study’s outcome variables did provide evidence “that the intervention
stimulated higher levels of effective interaction between patient and provider, as
intended, with significant effects on provider recommendations and patient intentions,
two strong predictors of screening behavior” (p. S 40). The number of reported
discussions regarding screening colonoscopy was twice as high as in the intervention
groups compared to the control groups.
Limitations were noted with regard to study design. Despite the inclusion of a
comparison group, there were no measures taken to randomly allocate study participants
to conditions. Furthermore, there was systematic recruitment as opposed to random
selection of the comparison group and its recruitment was done at an earlier time than
that of the intervention group. The lack of random allocation of study participants and
random selection of the comparison group opens the door for bias and make
generalizability questionable. In addition, although important predictors of screening
obtainment were apparent in the study outcomes, screening behaviors were not actually
assessed. According to the investigators, participant charts were also only partially
reviewed to determine whether screening actually occurred, due to insufficient resources.
Lastly, it is also important to note that the practices had higher than normal patient
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reported CRC screening rates, which indicates that such rates may be inaccurate due to
the self-reporting aspects of the assessment.
Ayanian et al. (2008). A randomized controlled trial was utilized to determine if mailing
patient-specific reminders to physicians would increase surveillance colonoscopy. An
automated EMR review was conducted and 777 patients were identified as having had
adenomatous colon polyps removed and having had no follow-up colonoscopy. The
intervention group consisted of 358 patients whose physicians received a reminder letter
notifying them that their patient was overdue for colorectal screening through
surveillance colonoscopy. The patient received a copy of the letter that incorporated
recommendations for colonoscopy and included instructions to contact their PCP for
proper scheduling. A blinded medical record review was conducted at 6 months and
assessed for completion of colonoscopy and for detection of adenomatous polyps and/or
cancer. This particular study focused on slightly higher risk patients as opposed to most
other studies that focused on patients of average risk. The study found that of those “358
patients whose physician received reminders, 33 (9.2%) patients underwent colonoscopy
within 6 months compared with 16 (4.5%) of 359 patients whose physicians did not
receive reminders (P=0.009) (p. 762).
Several limitations were noted to have potentially led to this marginal increase.
There was no direct communication with patients “to recommend surveillance
colonoscopy or to assess their reasons for not having this procedure” (p. 766).
Furthermore and as previously mentioned, physician notes were not assessed originally to
determine the completion of surveillance colonoscopy. This means that during a “posthoc visual review of medical records” investigators found out that almost “25% of
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patients had actually had a follow-up colonoscopy” before the intervention (p. 766). A
survey of physicians, who had patients in the intervention group, also revealed that over
“25% of patients were no longer active in the physicians’ practices” (p. 766). For these
patients there was a 5-year span during which they had not been seen by their former
PCP, which gives insight into the difficulties that are presented with guaranteeing proper
follow-up for patients requiring surveillance colonoscopy. This also highlights the need
for “information systems that facilitate communication among gastroenterologist,
primary physicians, and patients” (p. 766).
Ling et al. (2009). This paired randomized clinical trial sought to determine whether a
“tailored versus nontailored physician recommendation letter and an enhanced versus
nonenhanced physician office and patient management intervention” would have any
effect on adherence with CRC screening (p. 47). Ten primary care practices were
identified and yielded a sample of 599 patients that were CRC screen-eligible. The
primary targets for this study included (1) “office and patient management procedures
relating to the referral for endoscopic screening,” and (2) “the written communication
used to recommend endoscopic screening” (p. 53).
Although printed communications that are tailored, or personalized, tend to be
well received and are more memorable than telephone reminders for patients, this study
highlights that their effect is minimal in regard to changing a person’s health behavior.
This was partially attributed to the relatively small number of subjects allocated to each
group (n = 150), meaning the study had “limited power to detect clinically meaningful
effects from tailoring” – a common finding among similar studies (p. 53). The enhanced
office visit and patient management strategies “increased the odds of completing a
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colonoscopy or flexible sigmoidoscopy 1.63-fold (95% confidence interval, 1.11-2.41; P
= .01),” while the “tailored letter increased the odds of completion by only 1.08-fold
((95% confidence interval, 0.72-1.62; P =.71)” (p.47). Study data also revealed the
following colonoscopy rates: 1) 53.3% (81 of 152) for the tailored letter and enhanced
management group; 2) 54.2% (103 of 190) for the nontailored letter and enhanced
management group; 3) 43.6% (58 of 133) for the tailored letter and nonenhanced
management group; 4) 37.9% (47 of 124) of the nontailored letter and nonenhanced
management group.
A limitation was the “uncertainty regarding the rate of response (estimated
11.3%-13.9%) to mailed invitations to join the study” (p. 54). Furthermore, the low rate
of participation leads to concerns that the recruitment of patients could have potentially
chosen a group that was more accepting of endoscopic screening. Another issue with
recruitment relates to the method by which patients were actually included. Participants
were required to “(1) receive and open a mailing, (2) read and react favorably to its
contents, and (3) sign and return an unfamiliar consent form” (p. 54). Therefore, the
question arises, could face-to-face contacts in a clinical setting produce higher response
rates? Additional research is needed to investigate this variance in recruitment method.
Regardless of its limitations, this study demonstrates that “an enhanced office and patient
management system significantly improved screening adherence” (p. 54).
Sequist et al., 2009. This study demonstrates that, among patients who are considered to
be overdue for CRC screening, a modest increase in screening rates can be achieved
through personalized mailings, especially among older patients and by way of FOBT.
Screening rates were slightly higher among the patients that received reminders versus
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those who did not (44.0% vs 38.1%; P < .001). This finding suggests, “patients represent
an untapped resource for improving quality of care” (p. 368). Most patients deny ever
having received effective counsel from their PCP regarding CRC screening and its
importance; however, this study found that patients who are adequately informed about
preventative services usually take on a more active role in preventative care. The group
that received electronic physician reminders produced similar screening rates among
patients when compared to the control group (41.9% vs 40.2%; P = .47).
Unfortunately, the study demonstrates that electronic physician reminders did not
lead to a significant increase in CRC screening rates. This was attributed to the typically
long time span between patient primary care visits, as most patients never saw their PCP
during the study’s 15-month observation period. However, for patients that saw their PCP
3 or more times per year, the electronic reminders did produce an increase in screening
rates (59.5% vs 52.7%; P = .07), which was evidenced by an increased number of
colonoscopy orders. However, this modest increase in orders “did not produce a
corresponding increase in completed procedures, as nearly half of the patients” did not
follow through with the procedure (p. 369). This highlights the need for PCP to engage
in more effective communication with their patients and also highlights the need for
research to investigate the reasons why patients do not follow through with screening.
Discussion
Study results demonstrate that physician and patient reminders, regardless of their
source, can increase CRC screening rates. However, the increase is modest at best when
patient and provider reminders are used separately or as an exclusive CRC screening
intervention, which reiterates the need for reminders to target both the provider and
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patient and be used in combination (Ayanian et al., 2008, Geller et al., 2008, Ling et al.,
2009, & Sequist et al., 2009). The same was true with regard to patient and provider
education because CRC screening referral rates and CRC screening exam rates were
increased when CRC screening education targeted clinicians and patients (Geller et
al.2008, Ling et al., 2009, & Ornstein et al., 2010). Ineffective patient-provider
communication has led to low CRC screening referral rates among physicians and low
CRC screening exam rates among patients, which reveals that improper patient-provider
communication causes a low level of informed decision-making among CRC screening
eligible patients (Baker et al., 2009 and Ling et al., 2008). Electronic medical records are
useful, especially for auditing purposes, because it allows for provider feedback on
quality improvement interventions and goal attainment. However, when the EMR is used
to produce electronic provider reminders, their sole utilization as a means to increase
CRC screening recommendations and referrals may not be as viable as once believed
(Ayanian et al. 2008, Baker et al., Sequist et al., 2009). This reiterates the need for multistrategy CRC screening programs that combine patient- and provider-targeted
interventions.
A multi-strategy intervention that resulted in successful and sustained increases in
CRC screening rates contained several key components such as EMR audits and
subsequent feedback, combined patient and provider education and reminders, and the
use of non-physician staff to facilitate the screening process. The intervention was
structured as follows: (1) Baseline chart/EMR audit for CRC screening rates; (2)
Physician and non-physician (i.e. medical assistant or staff nurse) education regarding
CRC screening guidelines; (3) Implementation of expanded non-clinician staff roles (to
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act as CRC screening patient navigator to review of patient’s CRC screening status,
provide reminders to patient and physician regarding need for CRC screening, and
engage in post-visit discussion regarding importance of CRC screening/set up order for
colonoscopy when appropriate) (Ornstein et al., 2010). Although the intervention
requires restructuring of practice workflow and could take a significant amount of time
and resources to successfully implement, its impact on CRC screening has the potential to
be significant. However, a key point to consider with regard to the expansion of the nonclinician role is the potential for a breach in scope of practice. Implementing practices
would need to ensure that the tasks involved with the MA role expansion to facilitate
screening efforts were within the limits of the medical assistant scope of practice.
Table 1.
Literature Review: Synthesis of Key Findings

Synthesis of Key Findings
A multi-strategy intervention that is successful at achieving a sustained increase in
CRC screening rates contains several key components:
EMR Audits / Feedback
Combined Patient and Provider Education
Combined Patient and Provider Reminders
Use of non-provider staff to facilitate the screening process

An additional key point is that even though provider –focused CRC screening
interventions did produce an increase in the number of screening colonoscopy orders,
nearly 50% of the patients that received an order for screening colonoscopy did not
follow through with the procedure (Sequist et al., 2009). This highlights the need for
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further investigation to determine why patients do not follow through after a
recommendation and/or order for screening is provided.
Conclusion
Electronic medical records provide a useful means to facilitate CRC screening
efforts, but must effectively encourage complete documentation of screening status
among providers. Furthermore, EMRs can be utilized as a reminder source for CRC
screening, but should be combined with patient- and provider-targeted intervention
strategies to produce the best screening results. Effective patient-provider
communication is also a key factor in determining whether providers recommend CRC
screening and whether patients even consider completing a screening exam. This reveals
a need for provider education regarding effective communication skills and their
consequential effect on a patient’s informed decision-making process. Lastly, patients
represent an untapped resource for increasing CRC screening rates due to the fact that it
is not clear why patients fail to follow through with screening colonoscopy even after
receiving the recommendation and order for the exam.
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APPENDIX A
Author, Year,
Source
Ornstein,
Nemeth,
Jenkins, &
Nietert (2010)
Medical Care

Baker et al.
(2009) Quality
& Safety in
Health Care

Purpose/Focus of the
Study
“To assess the impact
of a quality
improvement
intervention
combining electronic
medical record (EMR)
based audit and
feedback, practice site
visits for academic
detailing and
participatory planning,
and the “best-practice”
dissemination on CRC
screening in primary
care practice” (p. 900).

To determine
whether the
implementation of a
three-phase
intervention

Study Design

Sample

Method

Two-year
group
randomized
trial

“Physicians,
midlevel
providers, and
clinical staff
members in 32
primary care
practices in 19
states caring for
68, 150 patients
50 years of age or
older” (p. 900).

- Practices included were in the
Practice Partner Research
Network (PPRnet) and use the
same EMR and pool quarterly
QI and research data.

Three-phase
Intervention
Study, Quasiexperimental

Patients 50+ yrs
seen between Jan.
1, 2003 and Oct.
31, 2006, and who
were not current
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-QI intervention conducted in
intervention group practices
between Jul. 1, 1007 and June
30, 2009 with 3 components:
(1) EMR-based audit and
feedback; (2) practice site
visits for academic detailing
and participatory planning; and
(3) “best-practice”
dissemination during annual
meetings.
-After 2-year intervention,
study practices repeated
structured EMR review and
update as done at baseline.
Three-phase intervention
program: 1. EMR reminders,
2. Physician and medical
assistant (MA) education
about CRC screening

Main Findings
-In intervention practices,
patients 50-75 years old
exhibited 60.7% to 71.2%
improvement in being UTD
with CRC screening than
patients in control practices
(from 57.7% to 62.8%)
-Screening recommendations
increased more in intervention
practices with adjusted
difference of 7.9% (CI 95%,
3.8%-6.1%)
-Wide interpractice variation
exhibited throughout
intervention

-Referral rate for colonoscopy
at baseline was 6.0%.
-Immediate screening rates
were minimally affected by
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program will
improve the rate of
CRC screening.

Geller et al.,
2008
Medical Care

A computer-based
intervention, the
Patient/Provider
Communication
Assistant (PPCA) was
developed and pilot
tested to “facilitate
discussion and
provider
recommendations for
CRC screening” (p.
S36). Hypothesis:
“Patients exposed to
the PPCA would be
more likely to have a
discussion with and
recommendation from
their provider, which
would lead to a plan to
receive CRC

for CRC screening
at time of visit.
Total of 152, 271
patient encounters.

Mixed model
analyses
using a
pre/post
quasiexperimental
design

Comparison group
– 177 patients
Intervention
group – 142
patients
Adult patients age
50-80 yrs.
Five family care
practices including
2 community health
centers with 12
physicians.
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guidelines, and 3. Redesign
of patient visit workflow with
expanded MA role to review
patients’ CRC screening
status and recommend
testing (when appropriate)
to improve the rate of CRC
screening.

provider education and
electronic reminders.

Computer tablet used to test
PPCA (collected data/
educated patients/printed
personalized patient/provider
notes to) ability to facilitate
discussions regarding CRC
screening.

After PPCA implementation,
providers discussed CRC
screening, especially
colonoscopy, more frequently
than with comparison group
(P-values=0.4 and o.o1,
respectively). CRC screening
was recommended by
providers more frequently to
patients in the intervention
group than in control group (P
= 0.02). Patients in the
intervention group planned to
be screened (specifically via
colonoscopy) more frequently
after intervention than in
comparison group (P = 0.003).
Between group and covariates,
no interaction found. PPCA
was considered to be easy to

Patient results compared
during comparison and
intervention periods on
provider CRC screening
discussions and
recommendations as well as
patient CRC screening
intentions. Age, literacy, and
education were examined and
used as covariate measures.

-There was a sustained increase
in colonoscopy referral order
rate to 13.4% with addition of
expanded MA role, a 123%
relative improvement.
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Ayanian,
Sequist,
Zaslavsky, &
Johannes
(2008) Journal
of General
Internal
Medicine

screening” (p. S36S37).
“To determine
whether surveillance
colonoscopy can be
increased among
overdue patients by
reminders to their
primary care
physicians” (p. 762).

Randomized,
controlled
trial

141 physicians in
2 Massachusetts
primary care
networks
“717 patients that
had colorectal
adenomas
removed 1995
thru 2000 and had
no follow-up
colonoscopy
identified via
automated review
of electronic
records through
Mar. 2006” (p.
762)

Physicians with patients in
intervention group received
a letter notification of
potential need for
colonoscopy. A letter was
also sent to the patients that
recommended colonoscopy
and encouraged them to
contact their physician to
schedule the colonoscopy.

Physicians were also given
response form with letter
“asking them to report
whether they intended to
send a reminder letter or call
each of their patients in the
intervention group to
Patients in
recommend colonoscopy” (p.
hospital affiliated
763). They were also asked
practices (n = 375) to report reasons why any
patient should not have the
Patients in
procedure.
integrated group
practice (n = 342)
Second letter and response
Patients
form was sent to physicians
randomized to
that did not respond within 1
month.
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use by 95% of all patients
regardless of age or education.
“Among 358 patients whose
physicians received reminders,
33 (9.2%) patients underwent
colonoscopy within 6 months,
compared with 16 (4.5%) of
359 patients whose physicians
did not receive reminders (P =
0.009)” (p. 762).
“New adenomas or cancer
were detected in 14 (3.9%)
intervention patients and 6
(1.7%) control patients (P =
0.06), representing 42.4% and
37.5% of patients who
underwent colonoscopy in each
group, respectively” (p. 762).
“Despite using advanced
electronic health records to
identify eligible patients,
22.5% of enrolled patients had
a prior follow-up colonoscopy
ascertained only by visual
record review, and physicians
reported 27.9% of intervention
patients were no longer active
in their practice” (p. 762).

ASSESSMENT OF PATIENT BARRIERS
control group (n
=359)

Ling et al.
(2009) Archives
of Internal
Medicine

The objective was “to
evaluate methods for
promoting colorectal
cancer screening in
primary care
practice” (p. 47).

2X2
Factorial
randomized
clinical trial

When 6-month observation
period was complete, “an
Patients
identical mailing was sent to
randomized to
intervention group the patients of the control
group to ensure their
(n = 358)
physicians were aware of the
potential need for
colonoscopy” (p. 763).
Study measured the “effects of
10 primary care
a tailored versus non-tailored
physician office
physician recommendation
practices, 599
letter and an enhanced versus
patients eligible
for screening aged non-enhanced physician office
and patient management
50-79 years
intervention on CRC screening
adherence” (p. 47).
“Primary end point was
medical-record-verified
flexible sigmoidoscopy or
colonoscopy” (p. 47).

289 patients out of 599
(48.2%) received lower
endoscopy over one-year
period.
More specifically, lower
endoscopy rates were as
follows:
-tailored letter and enhanced
management group 81 of 152
(53.3%)
-non-tailored letter and
enhanced management group
103 out of 190 (54.2%)

“Statistical end-point analysis
(according to randomization
-tailored letter and nonintent) used generalized
enhanced management group
estimating equations to account 58 out of 133 (43.6%)
for correlated outcomes
according to physician group”
(p. 47).
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-non-tailored letter and nonenhanced management group
47 out of 124 (37.9%)
1.63-fold increase in odds of
completing colonoscopy or
flexible sigmoidoscopy with
enhanced office and patient
management (95% CI, 1.112.41; P = .01).

Sequist,
Zaslavsky,
Marshall,
Fletcher, &
Ayanian (2009)
Archives of
Internal
Medicine

“To compare the
individual and joint
impact of
personalized
mailings to patients
and electronic
reminders to
primary care
physicians to
promote CRC
screening within a
multisite group
practice” (p. 364).

Randomized
controlled
trial

11 ambulatory
health centers
21, 860 patients
aged 50 to 80
years overdue for
CRC screening
110 primary care
physicians
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Patients were randomly
assigned to receive mailings
that contained education
pamphlet, FOBT kit, and
instructions for “direct
scheduling of flexible
sigmoidoscopy or
colonoscopy” (p. 364).
Physicians randomly assigned
“to receive electronic
reminders during office visits
with patients overdue” for
CRC screening (p. 364).

1.08-fold increase in odds of
completion with tailored letter
(95% CI, 0.72-1.62; P = .71).
Patients that received mailings
had higher screening rates than
those that didn’t (44.0% vs
38.1%; P < .001).
As age increased so did the
effect: +3.7% for ages 50-59
yrs; +7.3% for ages 60-69 yrs;
and +10.1% for ages 70-80 yrs
(for trend P = .01) (p. 364).
For patients whose physicians
received electronic reminders
and patients in the control
group, screening rates were
similar (41.9% vs 40.2%; P =
.47) (p. 364).
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Primary outcome – “Receipt of
FOBT, flexible
sigmoidoscopy, or
colonoscopy over 15 months”
(p. 364).

Among patients having 3+
primary care visits, electronic
reminders tended to increase
screening rates (59.5% vs
52.7%; P = .07) (p. 364).

Secondary outcome – detection
of colorectal adenomas
With patient mailings (5.7% vs
5.2%; P = .10) and physician
reminders (6.0% vs 4.9%; P =
.09) adenoma detection rates
were typically increased
(p.364).
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Assessment of Patient Barriers to and Facilitators of Screening Colonoscopy: Utilizing
patient perspectives to formulate recommendations to improve colorectal cancer
screening rates.

H. Nicole Barker Cox, RN, BSN, CGRN

University of Kentucky
College of Nursing
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Abstract
Background: Only a limited amount of research has been directed toward determining
patient factors that influence patient completion of screening colonoscopy. Most studies
have been provider-focused and have assessed multiple interventions formulated to
increase colorectal cancer (CRC) screening within the primary care setting. A pilot study
utilizing focused patient interviews to determine patient barriers to and facilitators of
screening colonoscopy was conducted. Recommendations for improving CRC were
formulated based on the interview results.
Methods: Participants included 25 in-patient adults age 50 years and older (mean age 65.1
years) admitted to a regional medical center. A qualitative approach was used to conduct
25 focused patient interviews from February 27th through March 9th, 2015 regarding CRC
screening history. The interviews were transcribed and systematically analyzed between
March and April 2015 to detect recurring patterns and themes related to screening
colonoscopy completion and/or lack thereof. Descriptive statistics were used to summarize
additional sample characteristics such as gender, education level, and income level.
Results: Among those who had received a screening colonoscopy (44%, 11 of 25),
provider recommendation was the most influential factor for procedure completion,
followed by the combination of provider plus family member recommendation.
Consequential findings revealed that due to Medical Necessity, several patients (32%, 8
of 25) had obtained a colonoscopy for non-screening purposes and were past due for
screening at the time of completion (75%, 6 of 8). Of the six patients who received an
initial colonoscopy out of medical necessity and were past due, half had never received a
prior recommendation, while the other half reported Lack of Insurance/Financial
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Concern(s) and Refusal/Fear as reasons for not completing colonoscopy at the time of
initial recommendation. Among those that had never had a colonoscopy for any reason
(24%, 6 of 25) barriers that were identified include 1) Lack of
Recommendation/Knowledge (50%, 3 of 6), 2) Lack of Insurance/Financial Concern(s)
(16.7%, 1 of 6), 3) Scheduling conflict (16.7%, 1 of 6), and 4) Refusal/Fear (16.7%, 1 of
6).
Conclusions: The findings of this quality improvement project identified facilitators and
barriers from the patient perspective as to why they participated in CRC screening. This
information will help providers provide appropriate education to patients and identify
potential barriers to obtaining a colonoscopy and address identified concerns.
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Among all cancer types, colorectal cancer (CRC) remains the third most common
and is the second leading cause of cancer-related deaths among both men and women in
the U.S. (Centers for Disease Control and Prevention [CDC], 2014a). It is estimated that
in 2014, 71,830 men and 65,000 women will be diagnosed with CRC in the United
States, and of those diagnosed, 26, 270 men and 24, 040 women will die (American
Cancer Society [ACS], 2014). Years of data have established that CRC incidence and
death rates increase with age. More specifically, “90% of new cases and 93% of deaths”
occur in those age 50 years and older (ACS, 2014 p. 5). Incidence rates are 25% higher in
African American individuals, while mortality rates are higher among men than women
in general by 30% to 40% (ACS, 2014).
Among screening-eligible adults aged 50 to 75 years, only one in three have had a
colonoscopy according to current CRC screening guidelines (Centers for Disease Control
and Prevention [CDC], 2013). Current screening guidelines state that adults aged 50 to 75
years should obtain one of the following screening exams: 1) Home fecal occult blood
test (FOBT) or fecal immunochemical test (FIT) yearly; 2) Flexible sigmoidoscopy every
five years, plus FOBT/FIT every three years; and/or 3) Colonoscopy every 10 years (U.S.
Preventative Services Task Force [USPSTF], 2008; Rex et al., 2009). Colonoscopy
remains the gold-standard screening exam for CRC as it allows for visualization of the
colon as well as the identification and removal of pre-cancerous lesions, or polyps.
Endoscopic removal of polyps during screening colonoscopy has the potential to prevent
up to 80% of colorectal cancers (U.S. Department of Health and Human Services [HHS],
n.d.).
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Although efforts to increase CRC screening awareness has led to an increase in
CRC screening rates from approximately 52% to 59% nation-wide, screening rates in the
U.S. still fall short of the American Cancer Society’s 2015 goal to screen 75% of those
eligible (U.S. Department of Health and Human Services [HHS], 2014; ACS, 2014).
Among eligible adults in the state of Kentucky, CRC screening rates remain low when
compared to other states. Statistics reveal that Kentucky’s CRC screening rate (59.3 –
63.5 per 100,000) is among the lowest when compared to other states, and it falls into the
highest rate categories for CRC incidence (42.7 – 48.9 per 100,000) and CRC- related
deaths (16.5 – 19.9 per 100,000) (Center for Disease Control and Prevention [CDC],
2014b).
Research findings were reviewed from studies that evaluated strategies to improve
CRC screening. Multiple strategies have been instituted in primary care practices to
increase provider adherence with CRC screening, and these have been evaluated for
effectiveness. The most successful CRC screening strategies are those that incorporate
screening activities at multiple points during the primary care experience and incorporate
a combination of patient-focused and provider-focused interventions (Baker et al., 2009;
Geller et al., 2008; Ornstein, et al., 2010; Sarfaty, M., 2009; and Sequist et al., 2009).
However, during the review process, a significant gap was identified.
Studies demonstrated that regardless of improvement in provider adherence to
assess for CRC risk and offer CRC screening, patients still failed to undergo CRC
screening, especially screening colonoscopy. Sequist et al. (2009) found that although
their intervention to improve provider adherence did result in a modest increase in
screening colonoscopy prescriptions, this increase “did not produce a corresponding
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increase in completed procedures, as nearly half of the patients” did not follow through
with the procedure (p. 369). Subsequent to this finding, an additional literature search
was performed to determine the barriers and/or facilitators to screening colonoscopy from
the patient perspective, but very few studies were found.
Provider recommendation was determined to be one of the most influential factors
to screening colonoscopy attainment among patients (Feeley, Cooper, Foels, & Mahoney,
2009; Sarfaty, 2008). Patients also identified that “knowing someone who has/had
cancer” was a key motivating factor in their decision to follow-through with CRC
screening” (Feeley et al., 2009, p. 304). Three of the most-reported patient-perceived
barriers were fear of the test, test discomfort/embarrassment, and fear of the test result
(Feeley et al., 2009). Because there were a limited number of studies investigating the
barriers to and facilitators of CRC screening from the patient perspective, a practice
inquiry project was developed.
Methods
Study Design
A pilot study utilized focused patient interviews to assess the CRC screening
history as well as barriers of and facilitators to screening colonoscopy among eligible
patients from February 27th through March 9th, 2015. Key findings were used to
formulate recommendations for future practice and research.
Sample
Participants were recruited from a convenience sample of in-patients admitted to
two Medical-Surgical/Orthopedic units at Frankfort Regional Medical Center.
Respondents included 25 adults who were selected from a sample of daily departmental
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census sheets from February 27th through March 9th, 2015 based on the following
inclusion criteria: 1) age 50 years or greater, 2) ability to comprehend and speak English,
and 3) ability to give informed consent. Those excluded from the sample included those
who were cognitively/developmentally unable to consent, who were deemed ward of the
state, were unresponsive and/or terminally ill. As per current CRC screening guidelines,
which indicate screening colonoscopy should begin at age 50, any adult 50 years and
older, who met the inclusion criteria, was given the opportunity to participate until the
sample size of 25 respondents was reached. Informed consent was obtained from each
participant prior to the interview. The Portsmouth Regional Hospital Institutional
Review Board approved this practice inquiry project.
Instruments
An interview tool was utilized during the focused interviews to guide the data
collection and interview process (see Appendix A). All answers were transcribed during
the time of the interview. Demographic information that was collected included
characteristics such as age, gender, ethnicity, education level, and income level.
Participants who reported completion of screening colonoscopy were asked to discuss the
factors that influenced their decision to complete the procedure, state the referral source
for screening, and the age at which the colonoscopy was completed. Participants who
denied ever receiving a screening colonoscopy were asked to state whether the procedure
had ever been recommended and if so, who recommended it. They were also asked to
discuss what factors contributed to their lack of procedure follow-through. At the
conclusion of the interview, all participants were given the opportunity to asked questions
regarding CRC screening/colonoscopy. Those who had never received screening were
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then asked to rate their likeliness to complete a screening colonoscopy on a 5-point Likert
scale– 5 “Very Likely”; 4 “Somewhat Likely”; 3 “Not Sure”; 2 “Not Very Likely”; and 1
“Not at all Likely.” All participants were given an educational handout from the
American college of Gastroenterology website entitled, “Test Your Knowledge of
Colorectal Cancer Screening” at the conclusion of the encounter, which covers CRC
statistics, risk factors and symptoms, importance of screening and screening
recommendations (American College of Gastroenterology [ACG], n.d.). The primary
investigator completed all encounter activities independently.
Data Analysis
The primary investigator, between February and April 2015, analyzed the
transcribed participant data utilizing constant comparative analysis to look for indicators
of categorical behaviors and/or events by which the data was then coded (Gillis &
Jackson, 2002). The transcribed data was entered as text into a series of Word document
tables to facilitate the analytical process. Demographic information was compiled into an
Excel spreadsheet and descriptive statistics were used to determine mean age, percentage
of male versus female, percentage of reported ethnicities, income, and education level.
Participants were divided into two major categories according to screening
colonoscopy status:1) Had Screening Colonoscopy (4 subcategories – On time, Early,
Late-No Prior Recommendation, and Late-Prior Recommendation) and 2) Has Never
Had Screening Colonoscopy. Among those who had not had a screening colonoscopy, a
third category emerged: Had Colonoscopy – Not Considered Screening (3 subcategories
– Early, Late-No Prior Recommendation, and Late-Prior Recommendation). Within the
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categories and subcategories, facilitator and/or barrier themes as well as overarching
themes were identified.
Results
There were a total of 25 participants who participated in this project. The mean
age was 65.1 years; 76.9% (19 of 25) were female and 23.1% (6 of 25) were male; and
96.2% (24 of 25) were Caucasian, while only 3.8% (1 of 25) were African American.
Sixty-four percent of the sample population reported an education level of high school
graduate or higher and 92% reported an income level of $50,000 or less per year.
Figure 1.
Education Level of Sample
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Figure 2.
Income Level of Sample
40%
35%
30%
25%
20%
15%
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5%
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Working
Lower Miiddle Upper Middle
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($15,000 ($32,000 ($72, 500 ($200,000 or
$25,000/yr) $50,000/yr) $100,000/yr)
more/yr)

Note. Income classes from Thompson, W. & Hickey, J. (2005) Society in Focus. Boston, MA: Pearson,
Allyn, & Bacon.

Facilitating Themes
Eleven of the 25 participants (44%) reported having received a screening
colonoscopy, over half of which were received late, or after the age of 50 years. Among
those eleven participants, 2 facilitating themes were identified that facilitated their ability
to complete the colonoscopy: 1) Provider Recommendation (10 of 11 participants;
90.9%) and 2) Provider Plus Family Member Recommendation (1 of 11 participants;
9.1%). The ten participants that received screenings solely based on provider
recommendation stated their primary care physician (PCP) “recommended/ suggested I
have it done” or “told me to have it done.” Three were screened on time (age 50), 2 were
screened early (before age 50), and 5 were screened late (over age 50). All five
participants who received late screening after the age of 50 (mean age 54.7 years),
reported that no prior recommendation was ever received. One participant (current age
73) stated, “My primary doctor recommended for the first time last year so I got it done.”
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The single participant who received screening based on Provider Plus Family Member
Recommendation, received screening late (at age 60) and stated, “My primary doctor
recommended it earlier but I refused to do it out of fear. My sister kept explaining how
important it was…that they take out polyps to prevent colon cancer, so I finally agreed to
do it.” In addition to provider plus family member recommendation, refusal/fear was
identified as an overarching barrier theme because despite repeated provider
recommendation, out of fear, the patient did not complete a screening colonoscopy until
additional family member recommendation was received.
Table 1.
Themes Identified Among Participants that Completed Screening Colonoscopy
Had Screening Colonoscopy (n=11)
n=
10

%
90.9

On time (age 50)
Early (before age 50)
Late (after age 50) – NO Prior Recommendation
Facilitator Theme II: Provider Plus Family Member
Recommendation

3
2
5
1

30
20
50
9.1

Late (after age 50) – Prior Recommendation
> Fear/Refusal (barrier)

1

9.1

Facilitator Theme I: Provider Recommendation

Note. The > indicates overarching barrier theme among the participant that 1) completed screening
colonoscopy, 2) received screening late (over age 50), and 3) received prior recommendation.

Barrier Themes
Six of the 25 participants (24%) reported that they had never received a screening
colonoscopy. The interview responses of these six participants revealed four barriers to
procedure completion: 1) Lack of Recommendation/ Knowledge, 2) Lack of Insurance/
Financial Concern(s), 3) Scheduling Conflict, and 4) Refusal / Fear. The Lack of
Recommendation/Knowledge theme was identified from statements: “It has never been
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recommended to me” (Female, age 72); “What is a colonoscopy? I have never heard of it
before” (Female, age 54); and “No one has ever recommended that I have it done”
(Female, age 53).
A second theme, lack of insurance/financial concern emerged. One man reported that he
had “an issue with his insurance” because it “wouldn’t pay for an upper scope and a
colonoscopy.” He stated, “at the time, the upper scope was more important…I am
supposed to get it (colonoscopy) but I have to make sure it is covered because I can’t
pay.”
The third theme, scheduling conflict was identified through, “I was supposed to
get it scheduled but I’ve been too busy and in and out of the hospital too much to get it
done.” The final theme of Refusal/Fear was determined from comments like, “I’ve been
told to do it but the thought of it has kept me from doing it” (Female, age 72).
Table 2.
Themes Identified Among Participants that Did Not Complete Screening Colonoscopy
Has Never Had Screening Colonoscopy (n=6)

n=

%

Barrier Theme I: Lack of Recommendation / Knowledge

3

50

Barrier Theme II: Lack of Insurance / Financial Concern(s)

1

16.7

Barrier Theme III: Scheduling Conflict

1

16.7

Barrier Theme IV: Refusal / Fear

1

16.7

A third category emerged from participants who had not received a screening
colonoscopy, but rather, had a colonoscopy due to compelling symptoms (i.e.
bleeding/bloody stool). The facilitating theme medical necessity was henceforth
identified among these patients. Eight of the 25 participants (32%) had received a
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colonoscopy that was not considered screening, but was completed due to medical
necessity. These eight participants were divided into early (colonoscopy before age 50)
and Late (colonoscopy over age 50), then further delineated in to Late – No Prior
Recommendation and Late – Prior Recommendation. Twenty-five percent (2 of 8
participants) received colonoscopy early: one patient reported receiving a colonoscopy at
age 30 because “she ate a lot of beets and it looked like blood” while another reported
that she “had a colonoscopy at 46 for bleeding.”

Of the remaining seventy-five percent

(6 of 8 participants), who received a colonoscopy after the age of 50 and due to medical
necessity, half had never received a prior recommendation. Comments such as “I had
bleeding (at age 53) and my doctor said I needed a colonoscopy” and “I was having
constipation, pain, and bleeding…I was 55 years old” were made meaning that although
Medical Necessity was considered a facilitator to colonoscopy completion, Lack of
Recommendation/ Knowledge could be identified as an overarching barrier theme. The
other half who had received prior recommendation, but did not complete the procedure
until it was medically necessary, gave statements from which two overarching barrier
themes were also revealed – Lack of Insurance/Financial Concern(s) and Refusal/Fear.
One participant had a colonoscopy at age 58 for bleeding, but reported that at time it was
previously recommended he “did not have insurance.” Another participant gave the
following statement:
“My first colonoscopy was 5 days ago. I was having pain and went
to the ER. They did a CT scan and it was abnormal with spots on my
liver so they admitted me. I had a colonoscopy and they found rectal
cancer. My family doctor told me to do it at age 50, but the co-pay to
see the GI doctor beforehand was way too expensive.”
-Female, age 55
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A third patient (Male, age 62) said he “had to have a colonoscopy at 57 because of a
bleeding ulcer that caused bleeding into [his] bowels.” He explained further that the
procedure was recommended at age 50, but that he “didn’t have it done because of the
thought of it – just didn't want to do it.”
Table 3.
Themes Identified Among Participants who had Colonoscopy- Not Considered Screening
Had Colonoscopy – Not Considered Screening (n=8)

n=

%

8

100

2
6

25
75

NO Prior Recommendation
> Lack of Recommendation/Knowledge (n=3)

3

50

Prior Recommendation
> Lack of Insurance / Financial Concern(s) (n=2)
> Refusal / Fear (n=1)

3

50

Facilitator Theme III: Medical Necessity*

Early (before age 50)
Late (over age 50)

Note. * Compelling symptom in all cases bleeding/bloody stool. The > indicates
overarching themes among those who completed colonoscopy that was 1) not
considered screening, 2) late (over age 50), and 3) either had not OR had received
prior recommendation.
Of the patients who reported receiving a recommendation for colonoscopy,
regardless of indication and/or age at time of screening, the PCP was the most-frequently
reported source of recommendation: PCP – 18 of 22 patients (81.8%); Specialist – 3 of 22
patients (13.6%); and Family Member – 1 of 22 patients (4.6%). Of the six patients who
had never received colonoscopy, a 5-point Likert-scale evaluated likeliness to complete
screening colonoscopy at the conclusion of the study encounter. All patients indicated
that they were either very likely (2 of 6 participants) or somewhat likely (4 of 6
participants) to complete screening colonoscopy at the conclusion of the encounter.
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Discussion
This quality improvement project revealed patient-identified facilitators and
barriers to screening colonoscopy. The findings are consistent with those reported by
Feeley et al. (2009), who utilized focus groups to determine perceived patient
barriers/facilitators to CRC screening and actual barriers/ facilitators to CRC screening
among providers and patients respectively. Similarities within the study findings
indicated that a recommendation for CRC screening is a key determinant of CRC
screening test completion. More specifically, patients indicated that they considered
provider recommendation to be most effective at facilitating CRC screening test
completion, while family member recommendation (i.e. spouse, child, or sibling) ranked
a close second (Feeley et al., 2009).
An additional facilitator to completion of screening colonoscopy, and/or any other
recommended CRC screening tests (i.e. FOBT/FIT and flexible sigmoidoscopy), was the
presence of CRC symptoms. When Feeley et al. (2009) asked patients to list “factors that
would influence higher screening rates,” having “symptoms of CRC” ranked high among
those listed, which is consistent with the findings in this study that not only revealed
medical necessity to be a facilitating theme, but also identified bleeding or bloody stool,
as the imposing symptom (p. 310).
Findings between both studies differed in that the most-frequently mentioned and
least-frequently mentioned barriers to CRC screening were reversed. Feeley et al. (2009)
reported that patients identified “fear of test” and “discomfort/embarrassment” as the
most-frequently mentioned barriers and “cost” concerns to be the least-frequently
identified barrier (p. 309). Another key difference was that this study focused on
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screening colonoscopy and did not include FOBT/FIT or flexible sigmoidoscopy
completion in its assessment of CRC screening.
This study also highlights the strength of lack of insurance/financial concern(s), or
cost, has on a patient’s ability to complete CRC screening because even in the presence
of CRC symptoms people still delay test completion. Even individuals with insurance
will delay or refuse CRC screening due to their inability to afford co-pays for office visits
and procedures.
Limitations
Due to the small sample size this is not an exhaustive list of patient-identified
barriers to and facilitators of screening colonoscopy. Feeley et al. (2009) identified a
total of seven patient-identified CRC screening barriers: fear of test, discomfort,
embarrassment, fear of results, lack of understanding, lack of time, cost (p. 309). In
current clinical practice, lack of transportation and reluctance to complete the bowel prep
are two additional barriers that patients have identified. Because participants were
recruited from only one site this may have led to a lack of diversity in population and
subsequent interview responses. A larger sample size and implementation of the study in
multiple sites may have resulted in more a more ethnically and socioeconomically diverse
population and may have revealed other/missing facilitators and barriers to CRC
screening (Polit & Beck, 2006; Gillis & Jackson, 2002). There is also a risk of intrinsic
bias due to the lack of both data source triangulation and investigator triangulation. By
utilizing multiple data sources (i.e. providers and patients) and more than one investigator
to collect, analyze, and interpret the data, credibility of the findings may have been
enhanced (Polit & Beck, 2006). Furthermore, this study only assessed screening
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colonoscopy; however, CRC screening can include FOBT/FIT and flexible
sigmoidoscopy and their completion among patients should have also been assessed.
Recommendations
The overarching goal is to increase the completion of CRC screening among
eligible patients. Studies have determined that practices wishing to achieve a sustained
increase in CRC screening rates among providers should implement a multi-strategy
CRC screening intervention program that utilizes EMR audits and feedback and includes
a combination of practice-, provider-, and patient-focused reminders and education
(Baker et al., 2009; Geller et al., 2008; Ling et al., 2009; Ornstein, et al., 2010; Sarafty,
M., 2008; & Sequist et al., 2009). Investigation into CRC screening improvement
strategies from the provider standpoint has been well established and its results have
shown that many interventions can lead to a subsequent increase in CRC screening test
orders (i.e. an approximate 53% to 60% increase in colonoscopy order per Sequist et al.,
2009). However, there has been very little inquiry as to why nearly half of the patients
who receive orders for CRC screening fail to follow through (Sequist et al., 2009).
Study findings reveal that providers must improve their efforts to overcome the
patient-identified barriers to CRC screening in order to increase CRC screening rates.
This indicates that there is a need for providers to assess what barriers exist for each
patient then formulate their recommendations according to those identified barriers. The
patient-identified barriers to CRC screening identified by this study include 1) lack of
provider recommendation; 2) lack of insurance/financial concerns; 3) Refusal/Fear; and
4) scheduling conflicts. The absence of provider recommendation can be overcome
through provider education that highlights consistent use of current CRC screening
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guidelines and strategies to improve provider-patient communication (Yoo, Kwon, &
Pfeiffer (2013). The lack of insurance and /or financial concern(s) can be remedied by:
1) assessing whether or not patients have health insurance; 2) determining what CRC
screening tests are covered by the insurance; and 3) offering the FOBT as per CRC
screening guidelines (Sarafty, M., 2008). To address the barrier of refusal/fear, providers
must engage in effective CRC screening discussions with their patients that focus on
CRC screening test options and then assess for patient understanding of the information
covered (Ling et al., 2008). Lastly, scheduling conflicts related to screening
colonoscopy completion could be remedied by providing patients with more convenient
and flexible scheduling options such as access to evening and weekend endoscopy
clinics, which are already available in some locations.
Implications for future research include the development and evaluation of a CRC
screening program that utilizes not only the key components of an evidence-based multistrategy practice intervention, but that also formulates its strategies to address the patientidentified barriers. With Americans gaining increased access to health insurance
coverage through The Affordable Care Act, the insurance gap may lessen for the current
and future screening-eligible populations (CDC, 2013). Additional research will be
needed to evaluate the effects of greater access to coverage on all cancer-related
screening activities.
Furthermore, although access to insurance has improved, this does not guarantee
the affordability of CRC screening. Even with insurance coverage, patients may not be
able to afford office visit or procedure co-pays. The cost of bowel preparation is also a
factor. Many providers offer improved bowel preparations that result in improved patient
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compliance and subsequent colonic visibility during colonoscopy. However, these
improved preps are also more expensive and most are not covered entirely by insurance
companies. Gastroenterology societies must advocate for the coverage of CRC
screening-associated costs, creating a major implication for policy.
Conclusion
CRC screening rates in primary care may be improved with implementation
of an evidence-based multi-strategy program that ensures its interventions are
based upon utilizing the patient-identified facilitators and addressing the patientidentified barriers to CRC screening exams.
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APPENDIX A
DATA COLLECTION/INTERVIEW TOOL
Age ____________
Sex: Male / Female
Ethnicity: ____________________
Education level:
Did not complete High School _____ GED ______ High School Graduate _______
Some College _____ College Graduate ______ Some Graduate Education _______
Completed Graduate Education _____
Income Level:
</= $10,000/yr ____ (lower) $15,000 - $25,000/yr ____ (working)
$32,000 - $50,000 ____ (lower middle) $72,500 - $100,00 ____ (upper middle)
$200,000 or more ____ (upper)
CRC Screening history: ____ Has had a screening colonoscopy.
____ Has not had a screening colonoscopy.
______________________________________________________________________________________
Interview Questions for Participants that HAVE HAD a Screening Colonoscopy:
Please discuss the factors that influenced your decision to complete a screening
colonoscopy:
_________________________________________________________________________________________________
_________________________________________________________________________________________________
_________________________________________________________________________________________________
_________________________________________________________________________________________________
_________________________________________________________________________________________________
_________________________________________________________________________________________________
_________________________________________________________________________________________________
_________________________________________________________________________________________________
Please identify the referral source for your screening colonoscopy (circle one):
Self referred / Primary Care Physician / Specialist
How old were you when you received your screening colonoscopy: ______________
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**Question & Answer Session**
______________________________________________________________________________________
Interview Questions for Participants that HAVE NOT had a Screening
Colonoscopy:
Has a screening colonoscopy ever been recommended to you? YES / NO
If so, by whom: Family member / Friend / Primary Care Physician / Specialist
If a screening colonoscopy has been recommended, what factors contributed
to you not following through? (Some commonly identified reasons include the
following.)
Fear of the procedure/ Fear of sedation / Do not want to take bowel prep /
Bad Experience by Family or Friend or Self / Financial reasons or concerns /
Lack of transportation / Do not feel it is important
Can you please elaborate?
_________________________________________________________________________________________________
_________________________________________________________________________________________________
_________________________________________________________________________________________________
_________________________________________________________________________________________________
_________________________________________________________________________________________________
_________________________________________________________________________________________________
_________________________________________________________________________________________________
_________________________________________________________________________________________________
_________________________________________________________________________________________________
_________________________________________________________________________________________________
_________________________________________________________________________________________________
_________________________________________________________________________________________________
**Question and Answer Session**
How likely are you to complete a screening colonoscopy after completing this
study encounter?
Very Likely Somewhat Likely
5
4

Not Sure Not Very Likely
3
2
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Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths
in the United States, and its negative impact can be reduced with completion of
recommended screening exams. However, approximately one in three screeningeligible adults have not been screened according the recommendations (CDC, 2013).
This striking quote by CDC Director, Tom Frieden, M.D., M.P.H., summarizes the
current situation:
More than 20 million adults in this country haven’t had
any recommended screening for colorectal cancer and
who may therefore get cancer and die from a preventable
tragedy (CDC, 2013).
Evidence shows that CRC screening rates in primary care can be improved with the
implementation of an evidence-based multi-strategy practice intervention program
that includes 1) EMR audits/feedback, 2) combined patient and provider education,
3) combined patient and provider reminders, and 4) utilizes non-provider staff to
facilitate the screening process (Baker et al., 2009; Sarfaty, 2008). These
interventions have resulted in increased rates for provider CRC screening
recommendations and an increase in the number of screening colonoscopies
ordered. However, despite the increase in colonoscopy orders, half of the patients
that receive those orders fail to follow through with the procedure (Sequist et al.,
2009). This practice inquiry project was conducted to determine the patientidentified barriers to and facilitators of screening colonoscopy.
Despite the study’s limitations, important implications for future practice,
research and policy were revealed. The findings were consistent with those of
Feeley et al. (2009) in that it determined provider recommendation to be most
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influential factor in determining whether a patient will complete a screening
colonoscopy. The importance of family member recommendation with regard to
exam completion was also highlighted. Patient-identified barriers included lack of
recommendation/ knowledge, lack of insurance/financial concern (s), scheduling
conflicts and refusal/fear. To overcome these barriers, providers must assess what
barriers exist for each patient and tailor their CRC screening recommendations
accordingly.
Overall study findings reveal that CRC screening rates in primary care may be
improved with the implementation of an evidence-based multi-strategy practice
program that ensures its interventions are 1) based upon utilizing the patientidentified facilitators and 2) address the patient-identified barriers to CRC screening
exams.
Future research may therefore benefit from the development and evaluation
of a CRC screening program that employs not only the key components of an
evidence-based multi-strategy practice intervention, but that also formulates its
strategies to address the patient-identified barriers. Additional research will also be
needed to determine the affect that The Affordable Care Act and its increased access
to health insurance has had on cancer-related screening activities. Furthermore,
increased access to coverage does not guarantee the affordability of CRC screening
and its related costs (i.e. co-pays, deductibles, and bowel preparations).
Gastroenterology societies must advocate for the affordability of CRC screening at
the policy level in order to ensure that cost-related barriers do not remain an issue
for patients – even those with health insurance coverage.
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